Physician

Kiren P Sahni

According to 2025 Medicare claims, Kiren Sahni (NPI: 1073932554) practices internal medicine in the Lakewood-New Brunswick, NJ market, with the plurality of this provider's patient population coming from Monmouth, NJ. This provider's primary affiliated billing organization is SAHNI RHEUMATOLOGY & THERAPY PC (NPI: 1821602194; TIN: 851265700) and primary practice location at 07764-1503.

Sahni's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 366 traditional Medicare patients, billed 197,798 HCPCS/CPT codes, and received $2,983,785 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 1,467 prescription claims across 340 beneficiaries totaling $660,411 in drug costs, led by Rinvoq (Upadacitinib). DME data shows 57 claims. Open Payments data shows 514 records totaling $263,581. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $1,148 to $2,983,785. Similarly, Part D prescription costs have risen steadily, from $873 to $660,411. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.5M$3.0M2017 Medicare payment: $1,148 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $3,703 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $3,039 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $3,896 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $927,864 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $2,523,693 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $2,947,640 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,983,785 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
20171119$1,148
20186183$3,703
20193863$3,039
20204555$3,896
202117976,767$927,864
2022255203,375$2,523,693
2023344199,258$2,947,640
2024366197,798$2,983,785

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$357K$713K2015 Drug cost: $873 (USD; Tot_Drug_Cst)2018 Drug cost: $9,766 (USD; Tot_Drug_Cst)2019 Drug cost: $12,402 (USD; Tot_Drug_Cst)2020 Drug cost: $1,312 (USD; Tot_Drug_Cst)2021 Drug cost: $271,365 (USD; Tot_Drug_Cst)2022 Drug cost: $713,191 (USD; Tot_Drug_Cst)2023 Drug cost: $623,575 (USD; Tot_Drug_Cst)2024 Drug cost: $660,411 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20151125$873
2016N/RN/RN/R
2017N/RN/RN/R
201867108$9,766
201988200$12,402
20204670$1,312
2021133688$271,365
20222361,189$713,191
20233111,158$623,575
20243401,467$660,411

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$29K$57K2022 Medicare payment: $19,941 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $57,240 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $36,858 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
20222424$19,941
20237879$57,240
20245757$36,858

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more140140$129
96413Administration of chemotherapy into vein, 1 hour or less131690$111
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more200275$103
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more213309$74
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's299501$13

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
RinvoqUpadacitinib29990$200,576
OtezlaApremilast12360$57,195
MethotrexateMethotrexate Sodium28021,366$10,375
LeflunomideLeflunomide1058,250$9,156
Hydroxychloroquine SulfateHydroxychloroquine Sulfate1209,060$6,230

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
L0631Lumbar-sacral orthosis, sagittal control, with rigid anterior and posterior panels, posterior extends from sacrococcygeal junction to t-9 vertebra, produces intracavitary pressure to reduce load on the intervertebral discs, includes straps, closures, may include padding, shoulder straps, pendulous abdomen design, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertiseN2525$22,919
L3916Wrist hand orthosis, includes one or more nontorsion joint(s), elastic bands, turnbuckles, may include soft interface, straps, prefabricated, off-the-shelfN3232$13,938

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.505$209,155Amgen Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.9$54,426Eli Lilly and Company
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Kiren P. Sahni?

Tedicare shows public-source Medicare data for Kiren P. Sahni (NPI 1073932554), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Kiren P. Sahni have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Kiren P. Sahni?

Kiren P. Sahni is linked to SAHNI RHEUMATOLOGY & THERAPY PC (billing NPI 1821602194) in the available physician profile data.

Does Kiren P. Sahni have Open Payments data?

Kiren P. Sahni has 514 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.